THRX insider filings
Theseus Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-14. Screen THRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for THRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Theseus Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-14 | 4 | Dahms Bradford D. — President and CFO | Code (U): 8,150.23 · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 332,114 (derivative) | EDGAR |
| 2024-02-14 | 4 | Yi Kathy — Director | Disposition to issuer (D): 3,250 (derivative) · Disposition to issuer (D): 99,634 (derivative) | EDGAR |
| 2024-02-14 | 4 | Dukes Iain D. — Director | Code (U): 388,324 · Disposition to issuer (D): 3,250 (derivative) · Disposition to issuer (D): 344,344 (derivative) · Disposition to issuer (D): 36,066 (derivative) · Disposition to issuer (D): 61,549 (derivative) | EDGAR |
| 2024-02-14 | 4 | Stein Steven H — Director | Disposition to issuer (D): 3,250 (derivative) | EDGAR |
| 2024-02-14 | 4 | GORDON CARL L — Director, 10% owner | Code (U): 17,063,000 · Code (U): 650,600 · Disposition to issuer (D): 3,250 (derivative) | EDGAR |
| 2024-02-14 | 4 | HAYDEN DONALD J JR — Director | Code (U): 10,000 · Disposition to issuer (D): 3,250 (derivative) | EDGAR |
| 2024-02-14 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner | Code (U): 17,063,000 · Code (U): 650,600 | EDGAR |
| 2023-11-07 | 4 | Shakespeare William — See Remarks | Option exercise (M): 251,084 @ $0.32 · Option exercise (M): 251,084 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Tananbaum James B. — 10% owner | Purchase (P): 523,450 @ $2.97 · Purchase (P): 176,550 @ $2.97 | EDGAR |
| 2023-07-19 | 4 | GORDON CARL L — Director, 10% owner | Purchase (P): 328,482 @ $3.05 · Purchase (P): 151,450 @ $3.05 | EDGAR |
| 2023-07-19 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner | Purchase (P): 328,482 @ $3.05 · Purchase (P): 151,450 @ $3.05 | EDGAR |
| 2023-06-13 | 4 | Yi Kathy — Director | Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Dukes Iain D. — Director | Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Stein Steven H — Director | Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | GORDON CARL L — Director, 10% owner | Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | HAYDEN DONALD J JR — Director | Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Rivera Victor — Chief Scientific Officer | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Shakespeare William — See Remarks | Grant/award (A): 21,250 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Kerstein David — Chief Medical Officer | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Dahms Bradford D. — Chief Financial Officer | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | CLACKSON TIMOTHY P — President and CEO, Director | Grant/award (A): 45,625 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Shakespeare William — See Remarks | Grant/award (A): 127,500 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Rivera Victor — Chief Scientific Officer | Grant/award (A): 97,500 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Kerstein David — Chief Medical Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Dahms Bradford D. — Chief Financial Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | CLACKSON TIMOTHY P — President and CEO, Director | Grant/award (A): 273,750 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Tananbaum James B. — 10% owner | Purchase (P): 250,000 @ $5 · Purchase (P): 250,000 @ $5 | EDGAR |
| 2023-01-03 | 4 | HAYDEN DONALD J JR — Director | Purchase (P): 100 @ $5 · Purchase (P): 9,900 @ $5.00 | EDGAR |
| 2022-12-01 | 4 | Dahms Bradford D. — Chief Financial Officer | Purchase (P): 1,502.19 @ $6.66 | EDGAR |
| 2022-11-14 | 4 | CLACKSON TIMOTHY P — President and CEO, Director | Purchase (P): 2,500 @ $6.80 | EDGAR |
| 2022-11-09 | 4 | GORDON CARL L — Director, 10% owner | Purchase (P): 192,000 @ $5.21 | EDGAR |
| 2022-11-09 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner | Purchase (P): 192,000 @ $5.21 | EDGAR |
| 2022-10-19 | 4 | Stein Steven H — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Yi Kathy — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Dukes Iain D. — Chairman, Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | GORDON CARL L — Director, 10% owner | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | HAYDEN DONALD J JR — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Kerstein David — Chief Medical Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Dalgarno David — Chief Technical Officer | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Dahms Bradford D. — Chief Financial Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Shakespeare William — See Remarks | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Rivera Victor — Chief Scientific Officer | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | CLACKSON TIMOTHY P — President and CEO, Director | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2022-01-21 | 4 | GORDON CARL L — Director, 10% owner | Purchase (P): 11,521 @ $9.97 · Purchase (P): 35,000 @ $9.95 · Purchase (P): 111,896 @ $9.97 | EDGAR |
| 2022-01-21 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner | Purchase (P): 11,521 @ $9.97 · Purchase (P): 35,000 @ $9.95 · Purchase (P): 111,896 @ $9.97 | EDGAR |
| 2022-01-13 | 4 | GORDON CARL L — Director, 10% owner | Purchase (P): 1,600 @ $9.81 · Purchase (P): 6,900 @ $10.67 · Purchase (P): 18,897 @ $10.06 · Purchase (P): 17,320 @ $9.43 | EDGAR |
| 2022-01-13 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner | Purchase (P): 1,600 @ $9.81 · Purchase (P): 6,900 @ $10.67 · Purchase (P): 18,897 @ $10.06 · Purchase (P): 17,320 @ $9.43 | EDGAR |
| 2021-12-22 | 4 | Dahms Bradford D. — Chief Financial Officer | Purchase (P): 1,970.04 @ $10.15 | EDGAR |
| 2021-12-22 | 4 | CLACKSON TIMOTHY P — President and CEO, Director | Purchase (P): 2,600 @ $9.76 | EDGAR |
| 2021-10-15 | 4 | TAKEDA PHARMACEUTICAL CO LTD — 10% owner ARIAD PHARMACEUTICALS INC — 10% owner | Conversion (C): 1,615,427 · Conversion (C): 1,615,427 (derivative) @ $0 | EDGAR |
Recent 8-K events — Theseus Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-02-14 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-27 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-31 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2023-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-05-25 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=THRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs